Takuya Fukumi, Hiroyuki Murakami, Takashi Moriyama, Tatsunori Ishikawa, Takanori Yoshioka, Masanori Makita, Kazutaka Sunami (National Hospital Organization Okayama Medical Center)
Session information
Poster Session
Sun. Oct, 14
Poster Session 3-24 Treatment for refratory/relapsed myeloma
Sun. Oct 14, 2018 1:00 PM - 1:40 PM Poster2 (Osaka International Convention Center, 5F Main Foyer)
Chair: Hitoshi Hanamoto (Department of Hematology Kindai University Nara hospital)
Shiro Ide, Shin Ohara, Tomoyuki Uchida, Morihiro Inoue, Jian Hua, Masao Hagihara (Department of Hematology, Eiju General Hospital, Tokyo, Japan)
[PS3-24-3] Efficacy and safety of carfilzomib for patients with relapsed/refractory multiple myeloma
Ayako Muramatsu1, Hiroaki Nagata1, Kodai Kuriyama1, Muneo Ohshiro1, Yoshiko Hirakawa1, Toshiki Iwai1, Hitoji Uchiyama1, Junya Kuroda2 (1.Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, 2.Devision of Hematology and Oncology, Kyoto Prefectural University of Medicine)
Hiroko Kawaguchi1, Mari Kitahara1, Nozomu Uematsu1, Tsutomu Shishido1, Takehiko Kirihara1, Keijiro Sato1, Toshimitsu Ueki1, Yuki Hiroshima1, Masahiko Sumi1, Mayumi Ueno2, Naoaki Ichikawa2, Hikaru Kobayashi1 (1.Department of Hematology, Nagano Red Cross Hospital, Nagano, Japan., 2.Department of Oncology, Nagano Red Cross Hosipital, Nagano, Japan)
Etsuko Sekimoto, Kengo Udaka, Hironobu Shibata, Toshio Shigekiyo, Shuji Ozaki (Department of Hematology, Tokushima Prefectural Central Hospital, Tokushima, Japan)
Michio Sawada1, Hideko Goto1, Hisashi Tsurumi2 (1.Department of hematology, Gifu red cross hospital, Gifu, Japan, 2.Department of hematology, Matsunami general hospital)
Takeshi Yoroidaka1, Hiroyuki Takamatsu1, Momoko Fujisawa1, Takeshi Yamashita2, Mikio Ueda2, Kosei Matsue3, Shinji Nakao1 (1.Hematol., Kanazawa Univ., Ishikawa, Japan, 2.Internal medicine, Keiju Medical Center, Ishikawa, Japan, 3.Hematol., Kameda Medical Center, Chiba, Japan)
Teruhito Takakuwa1, Ippei Otomaru1, Ayano Nishiura1, Akiko Miura1, Taku Araki1, Yotaro Fujitani1, Yasunobu Takeoka1,2, Ryosuke Yamamura1, Kensuke Ohta1 (1.Hematology, Osaka Saiseikai Nakatsu Hospital, Japan, 2.Hematology, Osaka City University, Japan)